Cargando…

Targeted Protein Degradation by Chimeric Compounds using Hydrophobic E3 Ligands and Adamantane Moiety

Targeted protein degradation using small chimeric molecules, such as proteolysis-targeting chimeras (PROTACs) and specific and nongenetic inhibitors of apoptosis protein [IAP]-dependent protein erasers (SNIPERs), is a promising technology in drug discovery. We recently developed a novel class of chi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shoda, Takuji, Ohoka, Nobumichi, Tsuji, Genichiro, Fujisato, Takuma, Inoue, Hideshi, Demizu, Yosuke, Naito, Mikihiko, Kurihara, Masaaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151680/ https://www.ncbi.nlm.nih.gov/pubmed/32106507 http://dx.doi.org/10.3390/ph13030034

Ejemplares similares

Development of Agonist-Based PROTACs Targeting Liver X Receptor
por: Xu, Hanqiao, et al.
Publicado: (2021)

Development of a Cell-penetrating Peptide that Exhibits Responsive Changes in its Secondary Structure in the Cellular Environment
por: Yamashita, Hiroko, et al.
Publicado: (2016)

Peptide Stapling Improves the Sustainability of a Peptide-Based Chimeric Molecule That Induces Targeted Protein Degradation
por: Yokoo, Hidetomo, et al.
Publicado: (2021)

Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs
por: Naito, Mikihiko, et al.
Publicado: (2019)

Development of ciclesonide analogues that block SARS-CoV-2 RNA replication
por: Tsuji, Genichiro, et al.
Publicado: (2021)

Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication
por: Tsuji, Genichiro, et al.
Publicado: (2022)

Development of Rapid and Facile Solid‐Phase Synthesis of PROTACs via a Variety of Binding Styles
por: Xu, Hanqiao, et al.
Publicado: (2022)

Selective Degradation of Target Proteins by Chimeric Small-Molecular Drugs, PROTACs and SNIPERs
por: Ishikawa, Minoru, et al.
Publicado: (2020)

Synthesis and Structural Properties of Adamantane‐Substituted Amines and Amides Containing an Additional Adamantane, Azaadamantane or Diamantane Moiety
por: Bonsir, Maxime, et al.
Publicado: (2022)

Development of a potent small‐molecule degrader against oncogenic BRAF(V600E) protein that evades paradoxical MAPK activation
por: Ohoka, Nobumichi, et al.
Publicado: (2022)

Critical role of mitochondrial ubiquitination and the OPTN–ATG9A axis in mitophagy
por: Yamano, Koji, et al.
Publicado: (2020)

Extent of Helical Induction Caused by Introducing α-Aminoisobutyric Acid into an Oligovaline Sequence
por: Tsuji, Genichiro, et al.
Publicado: (2018)

SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib
por: Ohoka, Nobumichi, et al.
Publicado: (2017)

Influence of Temperature and Salt Concentration on the Hydrophobic Interactions of Adamantane and Hexane
por: Bogunia, Małgorzata, et al.
Publicado: (2022)

Proteasome inhibitors prevent cell death and prolong survival of mice challenged by Shiga toxin
por: Hattori, Takayuki, et al.
Publicado: (2015)

Current Status of Oligonucleotide-Based Protein Degraders
por: Shih, Po-Chang, et al.
Publicado: (2023)

Control of STING Agonistic/Antagonistic Activity Using Amine-Skeleton-Based c-di-GMP Analogues
por: Yanase, Yuta, et al.
Publicado: (2022)

Development of protein degradation inducers of oncogenic BCR‐ABL protein by conjugation of ABL kinase inhibitors and IAP ligands
por: Shibata, Norihito, et al.
Publicado: (2017)

Synthesis and Properties of 1,3-Disubstituted Ureas Containing (Adamantan-1-yl)(phenyl)methyl Fragment Based on One-Pot Direct Adamantane Moiety Inclusion
por: D’yachenko, Vladimir, et al.
Publicado: (2023)

Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments
por: Munkuev, Aldar A., et al.
Publicado: (2021)

Anti-Inflammatory Activity of Soluble Epoxide Hydrolase Inhibitors Based on Selenoureas Bearing an Adamantane Moiety
por: Burmistrov, Vladimir, et al.
Publicado: (2022)

Lipidation of NOD2 Agonists with Adamantane and Stearoyl Moieties Differentially Regulates Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2022)

Pharmacological difference between degrader and inhibitor against oncogenic BCR-ABL kinase
por: Shibata, Norihito, et al.
Publicado: (2018)

Decoupling the effects of hydrophilic and hydrophobic moieties at the neuron–nanofibre interface
por: Martin, Adam D., et al.
Publicado: (2019)

Development of Hydrophobic Cell-Penetrating Stapled Peptides as Drug Carriers
por: Tsuchiya, Keisuke, et al.
Publicado: (2023)

Electronic spectroscopy of cationic adamantane clusters and dehydrogenated adamantane in helium droplets
por: Kappe, Miriam, et al.
Publicado: (2022)

Synthesis of 1,2-Disubstituted Adamantane Derivatives by Construction of the Adamantane Framework †
por: Todd, Matthew, et al.
Publicado: (2023)

1-Bromoadamantane
por: Betz, Richard, et al.
Publicado: (2008)

NAD-dependent isocitrate dehydrogenase as a novel target of tributyltin in human embryonic carcinoma cells
por: Yamada, Shigeru, et al.
Publicado: (2014)

Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties
por: Kovaleva, Kseniya, et al.
Publicado: (2021)

Adamantane-1-ammonium acetate
por: de Vries, Elise J. C., et al.
Publicado: (2011)

Adamantane-1-thioamide
por: Zahid, Maryam, et al.
Publicado: (2009)

Adamantane-1-ammonium benzoate
por: Zheng, Wen-Ni, et al.
Publicado: (2009)

Adamantanes for the prevention of COVID-19()
por: Cortés-Borra, Albert
Publicado: (2021)

Mouse‐Human Chimeric Antibody MH171 against the Multidrug Transporter P‐Glycoprotein
por: Ariyoshi, Keiko, et al.
Publicado: (1992)

1-(Bromomethyl)adamantane
por: Černochová, Jarmila, et al.
Publicado: (2011)

Bis(adamantan-1-aminium) carbonate
por: Nowakowska, Monika, et al.
Publicado: (2012)

N-Phenyladamantane-1-sulfinamide
por: Datta, Mrityunjoy, et al.
Publicado: (2008)

Cerebrovascular and Neuroprotective Effects of Adamantane Derivative
por: Mirzoyan, Ruben S., et al.
Publicado: (2014)

Hydrophobic Substituents of the Phenylmethylsulfamide Moiety Can Be Used for the Development of New Selective Carbonic Anhydrase Inhibitors
por: De Simone, Giuseppina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_37fnqu312ub5ac23nacft510of